CATO News
Indapamide: A Technical Review — From Synthetic-Route Impurities to the New Nitrosamine Regulatory Landscape
CATO|CATO|2026-09-14 11:48:30Impurity spectrum analysis of Tenofovir Disoproxil: selection of seven major categories of impurities and reference substances
Tenofovir Disoproxil (CAS 201341-05-1), a nucleotide drug that changes the landscape of antiviral treatment, is a nucleotide reverse transcriptase inhibitor (NtRTI) developed by the American company Gilead. It is one of the few approved for HIV (Human Immunodeficiency
cato|CATO|2026-08-31 17:39:09See You in Japan This September | CATO Invites You to JASIS 2026
JASIS 2026 · Chiba, Japan · Makuhari Messe See you by Tokyo Bay in Makuhari this September! CATO makes a proud appearance at JASIS 2026, Asia's largest analytical and scientific instruments exhibition. Booth No. 7B-802 September 2–4, 2026, in the global analytical and testing field,
cato|CATO|2026-08-31 15:42:24CATO Research Chemicals Celebrates Topping-Out of New Global Headquarters
On June 30, CATO Research Chemicals topped out the primary structure of its new global headquarters in Guangzhou — a ~30,466 m² campus combining R&D, testing, and client-facing space. The milestone marks a key step in CATO's transformation from a reference standards company into a broader chemical enterprise, with the new campus set to support two core business lines: pharmacopeial reference standards and new functional materials.
CATO|CATO|2026-07-03 14:32:44Join us at CPHI China 2026 !
I am penning this letter to extend a cordial invitation for you to visit our booth E2B47 at the forthcoming CPHI China 2026 in Shanghai. As a preeminent platform within the pharmaceutical industry, CPHI offers an unparalleled opportunity for us to reconnect with esteemed partners and delve into novel prospects in drug development and quality control.
||2026-05-29 16:42:07CATO CoA Upgrade:Professional Information at a Glance
CATO has upgraded the template for our Certificate of Analysis (CoA). The new certificate is now officially in use.
CATO|CATO|2025-09-12 16:18:37CATO Contributes to the Release of National Standard for Determining Isotopic Abundance in Deuterated Reagents
April 25, 2025 – Guangzhou, China — The State Administration for Market Regulation (SAMR) and the Standardization Administration of China (SAC) have officially released the national standard GB/T 45548-2025 Determination of Isotopic Abundance in Deuterated Reagents—Nuclear Magnetic Resonance (NMR) Spectroscopy.
CATO|CATO|2025-08-11 14:46:50CATO’s New Cosmetic Active Ingredient Series
As skincare formulation becomes more sophisticated, functional active ingredients are now central to product innovation and differentiation. For too long, the high-end cosmetic actives market has been dominated by a handful of global suppliers—resulting in high costs, long lead times, and limited sourcing flexibility for brands worldwide. To meet the growing demand for reliable, high-performance ingredients, CATO introduces its new Cosmetic Active Ingredient Series, featuring a diverse portfolio covering:
CATO|CATO|2025-08-04 11:05:15Notice on Packaging Change of CATO Products
Announcement on the Packaging Upgrade of CATO Reference Standards
CATO|CATO|2025-07-28 18:25:22REACH Annex XVII Adds New Restrictions on DMAC and NEP
On June 3, 2025, the European Union officially published Commission Regulation (EU) 2025/1090 in its Official Journal, introducing significant amendments to REACH Regulation Annex XVII by adding Articles 80 and 81. Two important industrial solvents—N,N-dimethylacetamide (DMAC) and 1-ethylpyrrolidin-2-one (NEP)—have been formally included in the restricted substances list.
CATO|CATO|2025-07-28 17:19:01



